Xie Y, Wang D, Jiang W T
Department of Liver Transplantation, the First Center Hospital of Nankai University, Tianjin 300110, China.
Tianjin Medical University First Center Clinical College, Tianjin 300070, China.
Zhonghua Gan Zang Bing Za Zhi. 2025 Apr 20;33(4):388-394. doi: 10.3760/cma.j.cn501113-20240528-00270. Epub 2024 Nov 20.
Liver transplantation is an effective treatment method for many end-stage liver diseases; however, the shortage of donor livers is one of the main obstacles affecting its development. Thus, xenotransplantation is expected to be a potential way to solve the shortage of organs. Gene editing technology has been used to improve animal genes so they can enhance their physiological compatibility with humans, and new immunosuppressive drugs are combined to reduce the occurrence of rejection so as to prolong the survival time of grafts. Liver xenotransplantation is more prominent than that of the heart or kidney transplants, and the related molecular mechanisms, such as xenogeneic rejection and coagulation disorders after surgery, need to be further studied due to the more complex structure and physiological functions of the liver. This paper reviews the historical development, current main problems, and clinical applications based on the latest research progress at home and abroad, with aim to improve clinicians' understanding of liver xenotransplantation.
肝移植是治疗多种终末期肝病的有效方法;然而,供肝短缺是影响其发展的主要障碍之一。因此,异种移植有望成为解决器官短缺问题的潜在途径。基因编辑技术已被用于改良动物基因,使其能增强与人类的生理相容性,并联合使用新型免疫抑制药物以减少排斥反应的发生,从而延长移植物的存活时间。肝异种移植比心脏或肾脏移植更为突出,由于肝脏结构和生理功能更为复杂,术后诸如异种排斥和凝血障碍等相关分子机制仍需进一步研究。本文基于国内外最新研究进展,综述肝异种移植的历史发展、当前主要问题及临床应用,旨在提高临床医生对肝异种移植的认识。